Abstract
Publication of clinical trial results in medical journals helps to inform the medical community of the efficacy and safety data available for new and existing drugs. However, publications reporting industry-sponsored research often undergo intense scrutiny and criticism. To ensure that these publications are developed in an ethical and scientifically rigorous manner, it is essential for companies to follow good publication practices. We review the various available guidelines that relate to preparing and publishing clinical research results, explore interpretations of the guidelines, and suggest ways to apply the principles from these guidelines to the publication development process.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
International Committee of Medical Journal Editors. Uniform requirements for manuscripts submitted to biomedical journals. JAMA. 1997;277: 927–954.
PhRMA. Principles on conduct of clinical trials and communication of clinical trial results. PhRMA: 2009. http://www.phrma.org/files/attachments/Clinical%20Trials.pdf (accessed June 8, 2010).
International Committee of Medical Journal Editors. Ethical considerations in the conduct and reporting of research: authorship and contributorship. http://www.icmje.org/ (accessed June 8, 2010).
Graf C, Battisti WP, Bridges D, et al. Research methods and reporting. Good publication practice for communicating company sponsored medical research: the GPP2 guidelines. BMJ. 2009;339:b4330.
Scott-Lichter D, and the Editorial Policy Committee. CSE’s white paper on promoting integrity in scientific journal publications. 2009 update. Reston, VA; 2009.
Noseworthy JH. Upcoming changes for authors. Neurology. 2007;69:2192.
American Medical Association. AMA Manual of Style. 9th ed. Philadelphia: Lippincott Williams and Wilkins.
Davis PJ. Gregerman RI. Parse analysis: a new method for the evaluation of investigators’ bibliographies. N Engl J Med. 1969;281:989–990.
Whellan DJ, Ellis SJ, Kraus WE, et al. Method for establishing authorship in a multicenter clinical trial. Ann Intern Med. 2009;151:414–420.
Horn D, Ehringhaus S. Principles for protecting integrity in the conduct and reporting of clinical trials. PLoS Clin Trials. 2006;1(1):e1.
Dowsett SA, Van Campcn LE, Bednar LA. Developing good scientific publishing practices: one pharmaceutical company’s perspective. Curr Med Res Opin. 2010;26:1249–1254.
DeAngelis CD, Fontanarosa PB. Ensuring integrity in industry-sponsored research primum non nocere. revisited. JAMA. 2010;303:1196–1198.
Matcham J, Julious S, Pyke S, et al. Proposed best practice for statisticians in the reporting and publication of pharmaceutical industry-sponsored clinical trials. Pharm Stat. 2010. DOI 10:1002/pst.412.
Drazen JM, Van Der Weyden MB, Sahni P, et al. Uniform format for disclosure of competing interests in ICMJE journals. 2009. http://www.icmje.org/format.pdf (accessed June 8, 2010).
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Zoog, H.B., Chang, T. Interpretation and Implementation of Good Publication Practice. Ther Innov Regul Sci 45, 137–144 (2011). https://doi.org/10.1177/009286151104500207
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1177/009286151104500207